Chronic hepatitis in HBsAg carriers with serum HBV-DNA and Anti-HBe

F. Bonino, F. Rosina, M. Rizzetto, R. Rizzi, E. Chiaberge, R. Tardanico, F. Callea, G. Verme

Research output: Contribution to journalArticle

313 Citations (Scopus)

Abstract

We compared the clinical and serologic features of 118 hepatitis B surface antigen carriers with hepatitis B e antibody (anti-HBe) followed up for 3-10 yr (mean 6.1 yr), separated according to the presence or absence of hepatitis B virus-deoxyribonucleic acid (HBV-DNA) in serum. The test was performed by molecular hybridization. There were 28 carriers with and 90 without viral DNA. Carriers with serum anti-HBe/HBV-DNA had major liver disease; cirrhosis developed during the follow-up period in 9 of the patients. All had the hepatitis B "core" antigen in the liver, localized prevalently in the cytoplasm of the hepatocytes. Among carriers of anti-HBe alone, 73 had persistently normal tests of liver function and 17 had abnormal levels of alanine transaminase and usually minor forms of liver damage at histology. In a group of 24 carriers of hepatitis B e antigen who spontaneously seroconverted to anti-HBe, hepatitis and a prevalent nuclear distribution of intrahepatic hepatitis B core antigen were found in temporal correlation with the presence of hepatitis B e antigen in serum. The replication of the hepatitis B virion terminated and liver disease remitted after seroconversion to anti-HBe. A positive HBV-DNA test in anti-HBe carriers is associated with a severe and evolutive liver disease and may provide an indication for treatment with drugs inhibiting the synthesis of HBV-DNA.

Original languageEnglish
Pages (from-to)1268-1273
Number of pages6
JournalGastroenterology
Volume90
Issue number5
Publication statusPublished - 1986

Fingerprint

Chronic Hepatitis
Hepatitis B Surface Antigens
Hepatitis B virus
Hepatitis B Core Antigens
Liver Diseases
Hepatitis B e Antigens
DNA
Serum
Hepatitis B Antibodies
Liver
Liver Function Tests
Viral DNA
Hepatitis B
Alanine Transaminase
Virion
Hepatitis
Hepatocytes
Histology
Cytoplasm
Fibrosis

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Bonino, F., Rosina, F., Rizzetto, M., Rizzi, R., Chiaberge, E., Tardanico, R., ... Verme, G. (1986). Chronic hepatitis in HBsAg carriers with serum HBV-DNA and Anti-HBe. Gastroenterology, 90(5), 1268-1273.

Chronic hepatitis in HBsAg carriers with serum HBV-DNA and Anti-HBe. / Bonino, F.; Rosina, F.; Rizzetto, M.; Rizzi, R.; Chiaberge, E.; Tardanico, R.; Callea, F.; Verme, G.

In: Gastroenterology, Vol. 90, No. 5, 1986, p. 1268-1273.

Research output: Contribution to journalArticle

Bonino, F, Rosina, F, Rizzetto, M, Rizzi, R, Chiaberge, E, Tardanico, R, Callea, F & Verme, G 1986, 'Chronic hepatitis in HBsAg carriers with serum HBV-DNA and Anti-HBe', Gastroenterology, vol. 90, no. 5, pp. 1268-1273.
Bonino F, Rosina F, Rizzetto M, Rizzi R, Chiaberge E, Tardanico R et al. Chronic hepatitis in HBsAg carriers with serum HBV-DNA and Anti-HBe. Gastroenterology. 1986;90(5):1268-1273.
Bonino, F. ; Rosina, F. ; Rizzetto, M. ; Rizzi, R. ; Chiaberge, E. ; Tardanico, R. ; Callea, F. ; Verme, G. / Chronic hepatitis in HBsAg carriers with serum HBV-DNA and Anti-HBe. In: Gastroenterology. 1986 ; Vol. 90, No. 5. pp. 1268-1273.
@article{7dba68417b4f4aeea4777c416fd29901,
title = "Chronic hepatitis in HBsAg carriers with serum HBV-DNA and Anti-HBe",
abstract = "We compared the clinical and serologic features of 118 hepatitis B surface antigen carriers with hepatitis B e antibody (anti-HBe) followed up for 3-10 yr (mean 6.1 yr), separated according to the presence or absence of hepatitis B virus-deoxyribonucleic acid (HBV-DNA) in serum. The test was performed by molecular hybridization. There were 28 carriers with and 90 without viral DNA. Carriers with serum anti-HBe/HBV-DNA had major liver disease; cirrhosis developed during the follow-up period in 9 of the patients. All had the hepatitis B {"}core{"} antigen in the liver, localized prevalently in the cytoplasm of the hepatocytes. Among carriers of anti-HBe alone, 73 had persistently normal tests of liver function and 17 had abnormal levels of alanine transaminase and usually minor forms of liver damage at histology. In a group of 24 carriers of hepatitis B e antigen who spontaneously seroconverted to anti-HBe, hepatitis and a prevalent nuclear distribution of intrahepatic hepatitis B core antigen were found in temporal correlation with the presence of hepatitis B e antigen in serum. The replication of the hepatitis B virion terminated and liver disease remitted after seroconversion to anti-HBe. A positive HBV-DNA test in anti-HBe carriers is associated with a severe and evolutive liver disease and may provide an indication for treatment with drugs inhibiting the synthesis of HBV-DNA.",
author = "F. Bonino and F. Rosina and M. Rizzetto and R. Rizzi and E. Chiaberge and R. Tardanico and F. Callea and G. Verme",
year = "1986",
language = "English",
volume = "90",
pages = "1268--1273",
journal = "Gastroenterology",
issn = "0016-5085",
publisher = "W.B. Saunders Ltd",
number = "5",

}

TY - JOUR

T1 - Chronic hepatitis in HBsAg carriers with serum HBV-DNA and Anti-HBe

AU - Bonino, F.

AU - Rosina, F.

AU - Rizzetto, M.

AU - Rizzi, R.

AU - Chiaberge, E.

AU - Tardanico, R.

AU - Callea, F.

AU - Verme, G.

PY - 1986

Y1 - 1986

N2 - We compared the clinical and serologic features of 118 hepatitis B surface antigen carriers with hepatitis B e antibody (anti-HBe) followed up for 3-10 yr (mean 6.1 yr), separated according to the presence or absence of hepatitis B virus-deoxyribonucleic acid (HBV-DNA) in serum. The test was performed by molecular hybridization. There were 28 carriers with and 90 without viral DNA. Carriers with serum anti-HBe/HBV-DNA had major liver disease; cirrhosis developed during the follow-up period in 9 of the patients. All had the hepatitis B "core" antigen in the liver, localized prevalently in the cytoplasm of the hepatocytes. Among carriers of anti-HBe alone, 73 had persistently normal tests of liver function and 17 had abnormal levels of alanine transaminase and usually minor forms of liver damage at histology. In a group of 24 carriers of hepatitis B e antigen who spontaneously seroconverted to anti-HBe, hepatitis and a prevalent nuclear distribution of intrahepatic hepatitis B core antigen were found in temporal correlation with the presence of hepatitis B e antigen in serum. The replication of the hepatitis B virion terminated and liver disease remitted after seroconversion to anti-HBe. A positive HBV-DNA test in anti-HBe carriers is associated with a severe and evolutive liver disease and may provide an indication for treatment with drugs inhibiting the synthesis of HBV-DNA.

AB - We compared the clinical and serologic features of 118 hepatitis B surface antigen carriers with hepatitis B e antibody (anti-HBe) followed up for 3-10 yr (mean 6.1 yr), separated according to the presence or absence of hepatitis B virus-deoxyribonucleic acid (HBV-DNA) in serum. The test was performed by molecular hybridization. There were 28 carriers with and 90 without viral DNA. Carriers with serum anti-HBe/HBV-DNA had major liver disease; cirrhosis developed during the follow-up period in 9 of the patients. All had the hepatitis B "core" antigen in the liver, localized prevalently in the cytoplasm of the hepatocytes. Among carriers of anti-HBe alone, 73 had persistently normal tests of liver function and 17 had abnormal levels of alanine transaminase and usually minor forms of liver damage at histology. In a group of 24 carriers of hepatitis B e antigen who spontaneously seroconverted to anti-HBe, hepatitis and a prevalent nuclear distribution of intrahepatic hepatitis B core antigen were found in temporal correlation with the presence of hepatitis B e antigen in serum. The replication of the hepatitis B virion terminated and liver disease remitted after seroconversion to anti-HBe. A positive HBV-DNA test in anti-HBe carriers is associated with a severe and evolutive liver disease and may provide an indication for treatment with drugs inhibiting the synthesis of HBV-DNA.

UR - http://www.scopus.com/inward/record.url?scp=0022641368&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022641368&partnerID=8YFLogxK

M3 - Article

C2 - 3956945

AN - SCOPUS:0022641368

VL - 90

SP - 1268

EP - 1273

JO - Gastroenterology

JF - Gastroenterology

SN - 0016-5085

IS - 5

ER -